Sign up to save your podcasts
Or
Share CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. Show references: https://www.nejm.org/doi/full/10.1056/NEJMoa2107454
View all episodes
By American Academy of Neurology
4.8
129129 ratings
Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. Show references: https://www.nejm.org/doi/full/10.1056/NEJMoa2107454
More shows like Neurology Minute
View all
JAMA Editors' Summary
130 Listeners
Neurology® Podcast
286 Listeners
NEJM This Week
319 Listeners
Practical Neurology Podcast
36 Listeners
JAMA Clinical Reviews
487 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Medical News
85 Listeners
Neurology Today in 5
23 Listeners
Annals On Call Podcast
181 Listeners
Navigating Neuropsychology
341 Listeners
The Clinical Problem Solvers
509 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
321 Listeners
Neurology Exam Prep Podcast
180 Listeners
The Curious Clinicians
361 Listeners
Continuum Audio
78 Listeners